Symphera

Munchen, Germany

Symphera provides an all-in-one surgical system that makes minimally-invasive procedures more efficient.

$2.8M raised

Sep 2024

Seed

Top Investors

HTGF (High-Tech Gruenderfonds)Bayern KapitalCarma FundIRCAD Institut de Recherche contre les Cancers de l'Appareil DigestifUnternehmerTUM

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Symphera

How much funding has Symphera raised?

Symphera has raised $2.8M in total funding. The most recent round was Seed. The last funding was announced in September 2024.

Who are Symphera's investors?

Symphera's investors include HTGF (High-Tech Gruenderfonds), Bayern Kapital, Carma Fund, IRCAD Institut de Recherche contre les Cancers de l'Appareil Digestif, UnternehmerTUM.

Where is Symphera headquartered?

Symphera is headquartered in Munchen, Germany.

What does Symphera do?

Symphera provides an all-in-one surgical system that makes minimally-invasive procedures more efficient.

What stage is Symphera at?

Symphera is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 16, 2024.

MLA

"Symphera — Funding & Investors." VCBacked, September 16, 2024, https://www.vcbacked.co/company/symphera. Accessed June 5, 2026.

APA

VCBacked. (2024). Symphera — Funding & Investors. Retrieved June 5, 2026, from https://www.vcbacked.co/company/symphera

Wikipedia (cite web)

{{cite web |title=Symphera — Funding & Investors |url=https://www.vcbacked.co/company/symphera |website=VCBacked |access-date=June 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 16, 2024.

Similar Companies in Manufacturing

Trillium Renewable Chemicals

Knoxville